PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17559747-8	2007	Initial clinical trial experience with the new oral DPP-4 inhibitors such as sitagliptin and vildagliptin suggests that these agents are weight-neutral, while providing improved glycaemic control when added to metformin.	Metformin	210-219	dipeptidyl peptidase 4	Homo sapiens	52-57	
17559747-10	2007	Initial clinical trial experience with oral DPP-4 inhibitors such as sitagliptin and vildagliptin suggest that these agents may represent an important oral treatment option for weight-neutral, glycaemic control when added to metformin.	Metformin	225-234	dipeptidyl peptidase 4	Homo sapiens	44-49